Private sector tuberculosis prevention in the US: Characteristics associated with interferon-gamma release assay or tuberculin skin testing

Keyphrases

• Tuberculosis Prevention 100%
• Tuberculin Skin Test 100%
• Interferon-gamma Release Assay 100%
• Tuberculosis 60%
• Latent Tuberculosis Infection 40%
• Bioassay Test 40%
• Private Healthcare 40%
• Logistic Regression Model 20%
• Risk Factors 20%
• Asthma 20%
• Multivariable Logistic Regression 20%
• Tobacco Use 20%
• Foreign-born 20%
• National Sample 20%
• Clinical Risk Factors 20%
• Population Density 20%
• End-stage Renal Disease 20%
• Risk Indicators 20%
• Administrative Data 20%
• Infection Surveillance 20%
• Commercially Insured 20%
• Immunosuppressive Therapy 20%
• Prevention Activities 20%
• Medical Claims 20%
• History of Tuberculosis 20%
• Infection Risk Factors 20%
• Pharmacy Claims 20%
• Tuberculosis-diabetes 20%
• Clinical Risk 20%

Medicine and Dentistry

• Tuberculin 100%
• Skin Test 100%
• Interferon Gamma Release Assay 100%
• Mantoux Test 80%
• Latent Tuberculosis 40%
• Logistic Regression Analysis 20%
• Diabetes 20%
• Human Immunodeficiency Virus 20%
• Asthma 20%
• Tobacco Use 20%
• Immunosuppressive Treatment 20%
• Alcoholic Polyneuropathy 20%
• Foreign Born 20%
• Population Density 20%
• End Stage Renal Disease 20%